Advertisement
News
Advertisement

BSX sees approval in Europe, Asia for new heart device

Mon, 09/24/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Boston Scientific Corp. (NYSE: BSX) has received approval to market an upgraded version of its implantable defibrillation lead device in Europe and Asia.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading